Wednesday February 10 2010 |
Biotechnology feed
|
All feeds
Home
Marketing Services
Antibodies
Careers
Directories
Drugs
Events
Genes
InDepth
News
Reports
Videos
A-Z
Business
Health
Drugs
Sources
Americas
Europe
Asia
Cancer
Cardio-
Diabetes
Bird Flu
Swine Flu
Summaries
Post News
Search
Lymphoma News and Headlines
Lymphoma News updated every 30 minutes from thousands of internet sites.
Sign-up to BioPortfolio's
Lymphoma
news alerts
.
Site Map
>
Biotechnology News
>
Health News
> Lymphoma
.
Lymphoma Research Foundation announces publication of Mantle Cell report
Genetic Engineering News:
similar ...
Glasgow research to improve cancer prevention
University Of Glasgow:
similar ...
Cell Therapeutics Lymphoma Drug Faces FDA Questioning
FOXBusiness.com:
similar ...
Cell Therapeutics Lymphoma Drug Faces FDA Questioning
FOXNews.com:
similar ...
Atopic Dermatitis: Researchers from Kaiser Permanente publish findings in atopic dermatitis
NewsRX:
similar ...
Seattle Genetics and Millennium Announce Initiation of Phase I Combination Clinical Trial of ...
PipelineReview:
similar ...
TenX Biopharma Pays Genmab $4.5M Up Front for Late-Stage T-Cell Lymphoma Antibody
Genetic Engineering News:
similar ...
Lymphoma Genetics: Study results from Karolinska Institut, Department of Microbiology provide new insights into lymphoma genetics
NewsRX:
similar ...
TopAbstracts in Lymphomas 02/03/2010
Doctors Guide:
similar ...
Love Stinks, Cancer Sucks II
San Francisco Chronicle:
similar ...
Brentuximab vedotin-chemotherapy combination clinical trial for Hodgkin lymphoma announced
News-Medical.Net:
similar ...
Seattle Genetics And Millennium Announce Initiation Of Phase I Combination Clinical Trial Of Brentuximab Vedot
Medical News Today:
similar ...
Seattle Genetics, Millennium start Phase I trial of brentuximab vedotin in Hodgkin lymphoma
Pharmacy Choice:
similar ...
Seattle Genetics and Millennium Announce Initiation of Phase I Combination Clinical Trial of Brentuximab Vedot
Pharmacy Choice:
similar ...
Seattle Genetics and Millennium Announce Initiation of Phase I Combination Clinical Trial of Brentuximab Vedotin (SGN-35) for Front-line Hodgkin Lymphoma
Freshnews.com:
similar ...
Seattle Genetics and Millennium Announce Initiation of Phase I Combination Clinical Trial of Brentuximab Vedotin (SGN-35) for Front-line Hodgkin Lymphoma
SmartBrief:
similar ...
Seattle Genetics and Millennium Announce Initiation of Phase I Combination Clinical Trial of Brentuximab Vedotin (SGN-35) for Front-line Hodgkin Lymphoma
Earthtimes.org:
similar ...
Seattle Genetics and Millennium Announce Initiation of Phase I Combination Clinical Trial of Brentuximab Vedotin (SGN-35
NewsBlaze:
similar ...
Seattle Genetics and Millennium Announce Initiation of Phase I Combination Clinical Trial of Brentuximab Vedotin (SGN-35) for Front-line Hodgkin Lymphoma
Your Story:
similar ...
Schneck to host blood cancer support group
TheBanner:
similar ...
